Sargent Bickham Lagudis’s Bausch Health BHC Stock Holding History

Sargent Bickham Lagudis’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,500	Closed	-$57K	–	1050
2022 Q1	$57K	Buy	+2,500	New	+$61.1K	﹤0.01%	424

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Sargent Bickham Lagudis's BHC Position: Q2 2022 in Review

Sargent Bickham Lagudis sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 2,500 shares — an estimated $57K sold.

Sargent Bickham Lagudis first reported a position in BHC in Q1 2022 and held it in 1 quarter. The position peaked at $57K in Q1 2022. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

Sargent Bickham Lagudis reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
Sargent Bickham Lagudis sold 2,500 Bausch Health shares in Q2 2022, an estimated $57K.
Sargent Bickham Lagudis first reported a position in Bausch Health in Q1 2022 and held it in 1 quarter.
Sargent Bickham Lagudis's Bausch Health position peaked at $57K in Q1 2022.
327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q2 2022, filed 13 Jul 2022.